400 Summit Drive
Burlington, MA 01803
T: (800)-645-5476
Twitter: @MilliporeSigma
Facebook: @MilliporeSigma


An Industry-Leading Portfolio of Formulation Products
Our portfolio of formulation products includes excipients for solid, semi-solid and liquid dosage forms for small and large molecules, allowing you to formulate APIs to your exact specifications and requirements. We offer both customized manufacturing and a standard portfolio of synthetic lipids and functionalized PEGs, biodegradable polymers for sustained release of small and large molecules and functional excipients for excellent performance in tableting processes, solubility enhancement and controlled release.

Parteck® Products for Solid Dosage Forms
With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid oral dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.

Polymers for Modified-Release Formulations of Biologics
Create long-acting sustained release formulations of proteins and large peptides in injectable formulations with our biodegradable polymer platform. Polymers are suitable for subcutaneous, intramuscular and site-specific injectable formulations in the form of microparticles and implants with high API doses of up to 100 mg/mL. 

Key benefits of our polymers include:

  • Robust and scalable production process
  • Excellent lot-to-lot robustness
  • High production yields
  • Suitable for continuous mode operation

PLA & PLGA Polymers for Modified Release Formulations of Small Molecules & Selected Peptides
PLA and PLGA biodegradable polymers optimize and provide better control of the release kinetics of final drug products. Additionally, nano- and microsphere formulations based on PLGA polymers can be used for the injectable delivery of peptides, therapeutic proteins, hormones and antibiotics, increasing patient comfort and compliance. The portfolio includes poly (D,L-lactic acid) (PLA) and poly (D,L-lactic-co-glycolic acid)(PLGA) polymers with varying polymer content and characteristics applicable for fine-tuning of sustained release of small molecule and selected peptide injectables. We also offer custom manufacturing capabilities for your unique polymer.